Definitive Healthcare Corp.
General ticker "DH" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $421.6M (TTM average)
Definitive Healthcare Corp. follows the US Stock Market performance with the rate: 15.7%.
Estimated limits based on current volatility of 3.7%: low 2.56$, high 2.75$
Factors to consider:
- Total employees count: 782 (-5.8%) as of 2024
- US accounted for 95.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Decline in demand for platform and data, Market competition, Data management issues, Geopolitical risks, Economic downturns and volatility
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.62$, 6.01$]
- 2025-12-31 to 2026-12-31 estimated range: [2.41$, 5.54$]
Financial Metrics affecting the DH estimates:
- Positive: with PPE of 12.0 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: negative Net income
- Positive: 41.86 < Shareholder equity ratio, % of 55.74 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: 6.82 < Operating cash flow per share per price, % of 11.93
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: Interest expense per share per price, % of 3.04 <= 3.41
- Negative: Investing cash flow per share per price, % of -5.41 <= -4.48
Short-term DH quotes
Long-term DH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $222.65MM | $251.41MM | $252.20MM |
| Operating Expenses | $266.70MM | $581.22MM | $963.02MM |
| Operating Income | $-44.04MM | $-329.80MM | $-710.82MM |
| Non-Operating Income | $2.17MM | $21.62MM | $77.08MM |
| Interest Expense | $11.20MM | $15.20MM | $14.84MM |
| R&D Expense | $34.89MM | $42.44MM | $36.52MM |
| Income(Loss) | $-41.88MM | $-308.18MM | $-633.75MM |
| Taxes | $-17.70MM | $-18.55MM | $-42.30MM |
| Profit(Loss)* | $-7.22MM | $-202.39MM | $-413.12MM |
| Stockholders Equity | $1,481.94MM | $1,199.17MM | $607.19MM |
| Assets | $2,122.62MM | $1,825.90MM | $1,089.39MM |
| Operating Cash Flow | $35.58MM | $41.19MM | $58.20MM |
| Capital expenditure | $8.33MM | $2.98MM | $12.34MM |
| Investing Cash Flow | $-248.90MM | $-31.78MM | $-26.41MM |
| Financing Cash Flow | $-26.70MM | $-25.58MM | $-56.75MM |
| Earnings Per Share** | $-0.07 | $-1.79 | $-3.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.